CHADDS FORD, Pa., March 1, 2012 /PRNewswire/ -- Endo (Nasdaq: ENDP), a diversified healthcare solutions company, today announced the aggregation of its operating companies as part of an enterprise-wide branding initiative. The integration of its diversified operating companies and the introduction of its new corporate identity reflect the company's significant transformation as a result of a series of recent strategic acquisitions and business development decisions.
In connection with this initiative, Endo Pharmaceuticals Holdings Inc., the parent company, will ask its shareholders to approve changing its name to Endo Health Solutions Inc. at its annual meeting of shareholders in May 2012.
With a uniquely diversified foundation of complementary healthcare businesses within well-defined therapeutic areas, the new Endo is structured to provide integrated, end-to-end solutions in pain management and urology. The vision is to approach therapeutic areas and disease states as pathways, and to identify, develop and incorporate medical interventions beyond the traditional chemical and biological treatments.
The company will deliver various products and services through its four operating companies: AMS, a developer of innovative medical devices; Endo Pharmaceuticals, a provider of branded pharmaceuticals; HealthTronics, a provider of medical services, practice management software, laboratory solutions and EHR technology; and Qualitest, a manufacturer of high-quality generic pharmaceuticals.
"With the right organizations in place, we have modernized our four distinct operating companies into one enterprise that reflects a powerful combination of compatible organizations aimed at delivering fully integrated healthcare solutions for the benefit of physicians, payers and patients," said Dave Holveck, President and CEO of Endo. "We are excited to
|SOURCE Endo Pharmaceuticals Holdings Inc.|
Copyright©2010 PR Newswire.
All rights reserved